Impact of Formulation and Microneedle Length on Transdermal Metronidazole Permeation Through Microneedle-Treated Skin

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2023 Dec 22

PMID 38133717

Authors

Krishna Kumar Patel

Nicole K Brogden

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to determine the impact of formulation (gel vs cream) and microneedle characteristics (length, number) on permeation of metronidazole through excised microneedle-treated skin. The long-term goal is to apply these results towards a pharmacokinetic study in human subjects with diverse skin types, using in vitro flux data to determine dosing conditions and ultimately establish in vitro-in vivo correlations.

Methods: Metronidazole release from 0.75% gel and cream was quantified with flow-through diffusion cells, using a cellulose membrane. Excised porcine skin was treated with stainless steel microneedles (500 or 800 μm length), to create 50 or 100 micropores. Metronidazole gel or cream was applied to microneedle-treated skin and replaced every 48 h for up to 7 days. Metronidazole permeation was quantified using HPLC. Intact skin (no microneedle treatment) served as controls.

Results: Metronidazole release was faster from the gel vs cream. At 7 days there was no difference between gel vs cream in total metronidazole permeated through intact skin. For both formulations, metronidazole permeation was significantly higher (vs intact skin) following microneedle application, regardless of microneedle length or micropore number. Increasing microneedle length and micropore number enhanced MTZ permeation multiple fold for both gel and cream. The greatest enhancement in total permeation for both formulations was achieved with the 800 μm MN, 100 micropore condition.

Conclusions: Formulation and microneedle conditions both impacted metronidazole permeation. These data will be used to estimate in vivo serum concentrations after applying metronidazole to microneedle-treated skin in humans.

Citing Articles

Validation of a sensitive bioanalytical method for metronidazole extraction from human plasma.

Patel K, Cota V, Brogden N J Pharm Biomed Anal Open. 2024; 3.

PMID: 39582498 PMC: 11583922. DOI: 10.1016/j.jpbao.2024.100025.

References

Vavrova K, Lorencova K, Klimentova J, Novotny J, Holy A, Hrabalek A . Transdermal and dermal delivery of adefovir: effects of pH and permeation enhancers. Eur J Pharm Biopharm. 2008; 69(2):597-604. DOI: 10.1016/j.ejpb.2007.12.005. View

Tokumoto S, Higo N, Sugibayashi K . Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin. Int J Pharm. 2006; 326(1-2):13-9. DOI: 10.1016/j.ijpharm.2006.07.002. View

Prausnitz M, Langer R . Transdermal drug delivery. Nat Biotechnol. 2008; 26(11):1261-8. PMC: 2700785. DOI: 10.1038/nbt.1504. View

Puri A, Frempong D, Mishra D, Dogra P . Microneedle-mediated transdermal delivery of naloxone hydrochloride for treatment of opioid overdose. Int J Pharm. 2021; 604:120739. DOI: 10.1016/j.ijpharm.2021.120739. View

Nalluri B, Uppuluri C, Devineni J, Nayak A, Nair K, Whiteside B . Effect of microneedles on transdermal permeation enhancement of amlodipine. Drug Deliv Transl Res. 2017; 7(3):383-394. DOI: 10.1007/s13346-017-0361-z. View

Oh J, Park H, Do K, Han M, Hyun D, Kim C . Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur J Pharm Biopharm. 2008; 69(3):1040-5. DOI: 10.1016/j.ejpb.2008.02.009. View

Russo J, Fiegel J, Brogden N . Rheological and Drug Delivery Characteristics of Poloxamer-Based Diclofenac Sodium Formulations for Chronic Wound Site Analgesia. Pharmaceutics. 2020; 12(12). PMC: 7765230. DOI: 10.3390/pharmaceutics12121214. View

Wermeling D, Banks S, Hudson D, Gill H, Gupta J, Prausnitz M . Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A. 2008; 105(6):2058-63. PMC: 2538880. DOI: 10.1073/pnas.0710355105. View

Phatale V, Vaiphei K, Jha S, Patil D, Agrawal M, Alexander A . Overcoming skin barriers through advanced transdermal drug delivery approaches. J Control Release. 2022; 351:361-380. DOI: 10.1016/j.jconrel.2022.09.025. View

10.

Zaid Alkilani A, McCrudden M, Donnelly R . Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. Pharmaceutics. 2015; 7(4):438-70. PMC: 4695828. DOI: 10.3390/pharmaceutics7040438. View

11.

Gao X, Brogden N . Development of Hydrogels for Microneedle-Assisted Transdermal Delivery of Naloxone for Opioid-Induced Pruritus. J Pharm Sci. 2019; 108(11):3695-3703. PMC: 6936750. DOI: 10.1016/j.xphs.2019.08.025. View

12.

Patel N, Patel N, Patel R . Comparative development and evaluation of topical gel and cream formulations of psoralen. Drug Discov Ther. 2012; 3(5):234-42. View

13.

Kirkby M, Hutton A, Donnelly R . Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations. Pharm Res. 2020; 37(6):117. PMC: 7266419. DOI: 10.1007/s11095-020-02844-6. View

14.

Ogunjimi A, Lawson C, Carr J, Patel K, Ferguson N, Brogden N . Micropore Closure Rates following Microneedle Application at Various Anatomical Sites in Healthy Human Subjects. Skin Pharmacol Physiol. 2021; 34(4):214-228. PMC: 8259462. DOI: 10.1159/000515454. View

15.

Song Y, Hemmady K, Puri A, Banga A . Transdermal delivery of human growth hormone via laser-generated micropores. Drug Deliv Transl Res. 2017; 8(2):450-460. DOI: 10.1007/s13346-017-0370-y. View

16.

Djekic L, Martinovic M, Stepanovic-Petrovic R, Micov A, Tomic M, Primorac M . Formulation of hydrogel-thickened nonionic microemulsions with enhanced percutaneous delivery of ibuprofen assessed in vivo in rats. Eur J Pharm Sci. 2016; 92:255-65. DOI: 10.1016/j.ejps.2016.05.005. View

17.

Gupta J, Gill H, Andrews S, Prausnitz M . Kinetics of skin resealing after insertion of microneedles in human subjects. J Control Release. 2011; 154(2):148-55. PMC: 3164267. DOI: 10.1016/j.jconrel.2011.05.021. View

18.

Ogunjimi A, Carr J, Lawson C, Ferguson N, Brogden N . Micropore closure time is longer following microneedle application to skin of color. Sci Rep. 2020; 10(1):18963. PMC: 7609754. DOI: 10.1038/s41598-020-75246-8. View

19.

Rath S, Kanfer I . A Validated IVRT Method to Assess Topical Creams Containing Metronidazole Using a Novel Approach. Pharmaceutics. 2020; 12(2). PMC: 7076423. DOI: 10.3390/pharmaceutics12020119. View

20.

Tobin K, Fiegel J, Brogden N . Thermosensitive Gels Used to Improve Microneedle-Assisted Transdermal Delivery of Naltrexone. Polymers (Basel). 2021; 13(6). PMC: 8002892. DOI: 10.3390/polym13060933. View